177 related articles for article (PubMed ID: 9050018)
21. Nifedipine attenuates both alpha-1 and alpha-2 adrenoceptor-mediated pressor and vasoconstrictor responses in conscious dogs and primates.
Woodman OL; Constantine JW; Vatner SF
J Pharmacol Exp Ther; 1986 Dec; 239(3):648-53. PubMed ID: 3025415
[TBL] [Abstract][Full Text] [Related]
22. Comparison of the effects of desipramine on noradrenaline- and methoxamine-evoked venoconstriction in man.
Abdelmawla AH; Langley RW; Szabadi E; Bradshaw CM
Br J Clin Pharmacol; 1995 Nov; 40(5):445-51. PubMed ID: 8703648
[TBL] [Abstract][Full Text] [Related]
23. Mechanisms mediating the positive inotropic and chronotropic changes induced by dopexamine in the anesthetized dog.
Bass AS; Kohli JD; Lubbers N; Goldberg LI
J Pharmacol Exp Ther; 1987 Sep; 242(3):940-4. PubMed ID: 2888876
[TBL] [Abstract][Full Text] [Related]
24. Induction by endogenous noradrenaline of an alpha 1-adrenoceptor-mediated positive inotropic effect in rabbit papillary muscles.
Hattori Y; Takeda Y; Nakaya H; Kanno M
Br J Pharmacol; 1993 Aug; 109(4):1232-8. PubMed ID: 8401934
[TBL] [Abstract][Full Text] [Related]
25. Effects of alpha 1- and alpha 2-adrenoceptor blocking drugs on noradrenaline release rate in anesthetized rabbits.
Majewski H; Rump LC; Hedler L; Starke K
J Cardiovasc Pharmacol; 1983; 5(5):703-11. PubMed ID: 6195454
[TBL] [Abstract][Full Text] [Related]
26. Effects of exogenous adrenaline and noradrenaline on vascular postsynaptic alpha 1- and alpha 2-adrenoceptors in man.
Jie K; van Brummelen P; Vermey P; Timmermans PB; van Zwieten PA
J Hypertens Suppl; 1984 Dec; 2(3):S119-21. PubMed ID: 6100733
[TBL] [Abstract][Full Text] [Related]
27. Bisoprolol attenuates noradrenaline- and phenylephrine-evoked venoconstriction in man in vivo.
Abdelmawla AH; Langley RW; Szabadi E; Bradshaw CM
Br J Clin Pharmacol; 1997 Jul; 44(1):61-8. PubMed ID: 9241098
[TBL] [Abstract][Full Text] [Related]
28. A prospective study of the effects of prolonged timolol therapy on alpha- and beta-adrenoceptor and angiotensin II receptor mediated responses in normal subjects.
Ferro A; Hall JA; Dickerson JE; Brown MJ
Br J Clin Pharmacol; 1997 Mar; 43(3):301-8. PubMed ID: 9088585
[TBL] [Abstract][Full Text] [Related]
29. Alpha-adrenoceptor stimulation with exogenous norepinephrine or release of endogenous catecholamines mimics ischemic preconditioning.
Bankwala Z; Hale SL; Kloner RA
Circulation; 1994 Aug; 90(2):1023-8. PubMed ID: 8044915
[TBL] [Abstract][Full Text] [Related]
30. Human cardiac beta1- or beta2-adrenergic receptor stimulation and the negative chronotropic effect of low-dose pirenzepine.
Jakubetz J; Schmuck S; Wochatz G; Ruhland B; Poller U; Radke J; Brodde OE
Clin Pharmacol Ther; 2000 May; 67(5):549-57. PubMed ID: 10824634
[TBL] [Abstract][Full Text] [Related]
31. Effects of atropine on human cardiac beta 1- and/or beta 2-adrenoceptor stimulation.
Bruck H; Ulrich A; Gerlach S; Radke J; Brodde OE
Naunyn Schmiedebergs Arch Pharmacol; 2003 Jun; 367(6):572-7. PubMed ID: 12759717
[TBL] [Abstract][Full Text] [Related]
32. Influence of calcium-entry blockade on vasoconstrictor responses in feline mesenteric vascular bed.
Lippton HL; Armstead WM; Hyman AL; Kadowitz PJ
Circ Res; 1987 Oct; 61(4):570-80. PubMed ID: 2443268
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of alpha-1 and alpha-2 adrenoceptor-mediated vasoconstriction in the in situ, autoperfused, pulmonary circulation of the anesthetized dog.
Shebuski RJ; Fujita T; Ruffolo RR
J Pharmacol Exp Ther; 1986 Jul; 238(1):217-23. PubMed ID: 3014116
[TBL] [Abstract][Full Text] [Related]
34. Comparison between isoprenaline infusions and bolus injections to assess beta-adrenoceptor function in man, with special reference to cardiac contractility and the influence of autonomic reflexes.
Martinsson A; Melcher A; Lindvall K; Hjemdahl P
Acta Physiol Scand; 1991 Feb; 141(2):167-80. PubMed ID: 1646559
[TBL] [Abstract][Full Text] [Related]
35. Vascular alpha-adrenoceptors in man: interactions with adrenaline and noradrenaline.
van Brummelen P; Jie K; Vermey P; Timmermans PB; van Zwieten PA
Clin Sci (Lond); 1985; 68 Suppl 10():151s-153s. PubMed ID: 2982538
[TBL] [Abstract][Full Text] [Related]
36. The effect of angiotensin II on haemodynamic and plasma noradrenaline responses to tyramine infusion in man.
Seidelin PH; Struthers AD
Eur J Clin Pharmacol; 1991; 41(2):119-23. PubMed ID: 1743243
[TBL] [Abstract][Full Text] [Related]
37. Cardiovascular responses to the stimulation of alpha-1 and alpha-2 adrenoceptors in the conscious dog.
Woodman OL; Vatner SF
J Pharmacol Exp Ther; 1986 Apr; 237(1):86-91. PubMed ID: 2870177
[TBL] [Abstract][Full Text] [Related]
38. Effects of yohimbine, an alpha 2-adrenoceptor antagonist, on experimental neurogenic orthostatic hypotension.
Verwaerde P; Tran MA; Montastruc JL; Senard JM; Portolan G
Fundam Clin Pharmacol; 1997; 11(6):567-75. PubMed ID: 9444525
[TBL] [Abstract][Full Text] [Related]
39. Comparison of the effects of nadolol and bisoprolol on noradrenaline-evoked venoconstriction in man in vivo.
Abdelmawla AH; Langley RW; Szabadi E; Bradshaw CM
Br J Clin Pharmacol; 1998 Mar; 45(3):271-6. PubMed ID: 9517371
[TBL] [Abstract][Full Text] [Related]
40. Ageing and leg postjunctional alpha-adrenergic vasoconstrictor responsiveness in healthy men.
Smith EG; Voyles WF; Kirby BS; Markwald RR; Dinenno FA
J Physiol; 2007 Jul; 582(Pt 1):63-71. PubMed ID: 17463044
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]